EMEA, U.S. FDA Sign Transatlantic ‘Simplification’ Pact

International Pharmaceutical Regulatory Monitor
A A
The European Medicines Agency (EMEA) and the U.S. Food and Drug Administration (FDA) will collaborate on a range of projects aimed at simplifying and streamlining administrative practices and guidelines relating to drugs.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $20.00